文献速递颈动脉与弓上血管

经颈动脉血运重建中动态血流逆转是降低卒中的主要机制

Primary mechanism of stroke reduction in transcarotid artery revascularization is dynamic flow reversal.
PubMed 文献 · J Vasc Surg · 2020-12-01

TCAR组院内卒中/死亡、卒中及卒中/死亡/心梗复合风险均显著低于TCAS-DEP组。倾向性匹配后卒中/死亡和卒中风险仍较低,但复合终点无差异。避免主动脉弓未降低卒中率,提示动态血流逆转是主要神经保护机制。

要点

  • TCAR较TCAS-DEP显著降低院内卒中/死亡(1.6% vs 5.2%,OR 0.35)和卒中(1.4% vs 4.2%,OR 0.37)。
  • 倾向性匹配后TCAR仍降低卒中/死亡(1.1% vs 4.7%,RR 0.23)和卒中(0.4% vs 4.0%,RR 0.09)。
  • 避免主动脉弓未降低卒中率,动态血流逆转是主要神经保护机制。

核心结论

  • 与TCAS-DEP相比,TCAR与较低的围术期卒中或死亡及卒中风险相关。
  • 动态血流逆转可能比远端栓塞滤器提供更好的神经保护。
  • 避免主动脉弓并未降低卒中率。

研究设计与样本

  • 共纳入8426例患者,其中TCAS-DEP组287例(3.4%)。
  • 采用多变量逻辑回归和最近邻倾向性评分匹配分析比较两组结局。

临床怎么用

  • 经颈动脉途径行颈动脉支架术时,优先选择动态血流逆转而非远端栓塞保护,以降低围术期卒中或死亡风险。
  • 避免主动脉弓操作本身未显示降低卒中率,神经保护效应主要来自动态血流逆转。

局限性

  • 为回顾性数据库分析,非随机对照,可能存在选择偏倚。
  • TCAS-DEP组样本量较小(n=287),可能影响统计效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recent studies have suggested that the low risk of stroke and death associated with transcarotid artery revascularization (TCAR) is partially attributable to a robust dynamic flow reversal system and the avoidance of the atherosclerotic aortic arch during stenting. However, the benefits of flow reversal compared with distal embolic protection (DEP) in reducing stroke or death in TCAR have not been studied. METHODS: All patients undergoing carotid artery stenting (CAS) via the transcarotid route with either dynamic flow reversal (TCAR) or DEP (TCAS-DEP) in the Vascular Quality Initiative from September 2016 to November 2019 were analyzed. Both multivariable logistic regression and nearest neighbor propensity score-matched analysis were performed to explore the differences in outcomes between the two procedures. The primary outcome was in-hospital stroke or death. The secondary outcomes were stroke, death, myocardial infarction (MI), and the composite of stroke, death, and MI. A secondary analysis was performed to compare transcarotid stenting with DEP vs transfemoral CAS with DEP to evaluate the effects of crossing the aortic arch. RESULTS: A total of 8426 patients were identified (TCAS-DEP, n = 287; 3.4%). TCAR was associated with a lower risk of in-hospital stroke or death (1.6% vs 5.2%; odds ratio [OR], 0.35; 95% confidence interval [CI], 0.20-0.64; P = .001), stroke (1.4% vs 4.2%; OR, 0.37; 95% CI, 0.20-0.68; P = .002), and stroke/death/MI (2.0% vs 5.2%; OR, 0.41; 95% CI, 0.23-0.71; P = .001) compared with TCAS-DEP. Among the 274 pairs of patients identified with propensity score matching, TCAR was associated with a lower risk of stroke/death (1.1% vs 4.7%; risk ratio [RR], 0.23; 95% CI, 0.06-0.81; P = .021) and stroke (0.4% vs 4.0%; RR, 0.09; 95% CI, 0.01-0.70; P = .006) compared with TCAS-DEP but no differences in stroke/death/MI (1.8% vs 4.7%; RR, 0.38; 95% CI, 0.15-1.02; P = .077). The secondary analysis found no differences in stroke between TCAS-DEP and transfemoral CAS with DEP (4.9% vs 3.7%; RR, 1.3; 95% CI, 0.36-1.63; P = .65). CONCLUSIONS: Compared with TCAS-DEP, TCAR was associated with a lower risk of perioperative stroke or death and stroke. This finding implies that dynamic flow reversal might provide better neuroprotection than does a distal embolic filter in reducing the perioperative risk of stroke. Avoiding the aortic arch did not confer any reduction in the stroke rate. The present findings serve to separate the clinical benefit of dynamic flow reversal from that of avoiding the aortic arch during TCAR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Naazie IN, Magee GA, Mathlouthi A, et al. Primary mechanism of stroke reduction in transcarotid artery revascularization is dynamic flow reversal. J Vasc Surg. 2020. PMID: 33276041. doi:10.1016/j.jvs.2020.10.082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。